Skip to content

Prediction and clinical application of gestational diabetes risk based on deep learning and genomic information

Prediction and clinical application of gestational diabetes risk based on deep learning and genomic information

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069497
Enrollment
Unknown
Registered
2023-03-20
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

birth defects

Interventions

Group of special pregnant women:None

Sponsors

Obstetrics&Gynecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Subjects in the training set and test set GDM pregnant group must meet all of the following criteria: 1. Complete patient sociological and clinical profile; 2. No pre-pregnancy diabetes, i.e., pre-pregnancy does not meet fasting blood glucose concentration >= 7.0 mmol/L or HbA1c level >= 6.5%; suffer from GDM after pregnancy, i.e. meets the diagnostic criteria for GDM. ogtt meets FTG >= 5.1 mmol/L, 1 h post-sugar administration blood glucose concentration >= 10.0 mmol/L, 2 h post-sugar administration blood glucose concentration >= 8.5 mmol/L, meets the above Any one of the above can confirm the diagnosis of GDM11; 3. Complete liver and kidney function examination data, no major medical or surgical diseases combined. Subjects in the training and test sets of normal pregnant control subjects must meet all of the following criteria: 1. Complete sociological and clinical profile of the subject; 2. No pre-pregnancy diabetes, i.e., no pre-pregnancy fasting blood glucose concentration >= 7.0 mmol/L or HbA1c level >= 6.5%; no post-pregnancy gestational diabetes, i.e., no one of the following three GDM diagnostic criteria: OGTT: FTG >= 5.1 mmol/L, 1 h post-sugar administration blood glucose concentration >= 10.0 mmol/L, 2 h post-sugar administration blood glucose concentration >= 8.5 mmol/L; 3. Complete information on liver and kidney function tests, no major medical or surgical diseases.

Exclusion criteria

Exclusion criteria: 1. Subjects with > 20% missing observations; 2. Other conditions deemed by the investigator as unsuitable for enrollment.

Design outcomes

Primary

MeasureTime frame
Accuracy of early screening models for GDM;

Secondary

MeasureTime frame
Type of variables for the input model;Number of variables in the input model;Correlation of variables with the occurrence of GDM;

Countries

China

Contacts

Public ContactXu Chenming

Obstetrics&Gynecology Hospital of Fudan University

chenming_xu2006@163.com+86 21 64073897

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026